Both USEF and FEI list natural cannabinoids, synthetic cannabinoids, and other cannabimimetics as prohibited substances. USEF Equine Drugs and Medications Rules prohibit CBDs and their metabolites in show horses, which are likely to effect the performance of a horse due to its reported anxiolytic effects. This substance is no different than legitimate therapeutics that effect mentation and behaviour in horses.

Horses competing under USEF rules who test positive for CBD will be considered in violation beginning Sept. 1, 2019. As published literature does not exist noting detection times of these substances in the horse, and because products can widely vary in their compositions and concentrations, detections prior to Sept. 1 will receive warnings and will be considered to be in prior violation if there are additional CBD detections following that date.

Regarding CBD legalization for use in Canada, Jean Szkotnicki, president of the Canadian Animal Health Institute, explained, “Health Canada’s Veterinary Drugs Directorate is responsible for the review of data in support of a Drug Identification Number (DIN) being issued for a product,” she explained. “A DIN gives a company the right to market a product. Then the Regional Operation and Enforcement Branch has to ensure the product meets quality standards once in the marketplace.”

Advertisement